ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.

Valentina Boni,Ira Winer,Lucy Gilbert,Ulka N. Vaishampayan,Seth David Rosen,Jameel Muzaffar,Anna Spreafico,David F. McDermott,Quincy Chu,Olivier Dumas,Aman Chauhan,Arvind Chaudhry,Piotr Tomczak,Debora S. Bruno,Yangchun Du,Ilda Bidollari,Jessicca Martin Rege,Marc S. Ernstoff,James Strauss,Vamsidhar Velcheti

ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.

2021

2513Background: Nemvaleukin alfa (nemvaleukin, ALKS 4230) is a novel, engineered cytokine that selectively binds the intermediate-affinity interleukin-2 (IL-2) receptor complex to preferentially ac...

Keywords:

receptor complex
in patient
Cancer research
Cytokine
Medicine
Pembrolizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations